T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.55% |
| 2 | Healthcare | 16.29% |
| 3 | Consumer Discretionary | 15.56% |
| 4 | Financials | 12.85% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Tenable Holdings
TENB
$4.3B
| $5.39M | ﹤0.01% |
148,923
+130,949
| +729% | +$5.92M |
|
|
GTM
1452
ZoomInfo Technologies
GTM
$1.19B
| $5.38M | ﹤0.01% |
110,046
+4,470
| +4% | +$225K |
|
1453
Patria Investments
PAX
$1.84B
| $5.36M | ﹤0.01% |
+307,406
| New | +$5.9M |
|
1454
Universal Display
OLED
$4.17B
| $5.26M | ﹤0.01% |
22,206
-245
| -1% | -$56.6K |
|
1455
Karyopharm Therapeutics
KPTI
$45.3M
| $5.19M | ﹤0.01% |
32,864
-64,263
| -66% | -$13.5M |
|
1456
Gaming and Leisure Properties
GLPI
$12.7B
| $5.13M | ﹤0.01% |
121,028
+2,035
| +2% | +$86.2K |
|
1457
TIM SA
TIMB
$8.25B
| $5.13M | ﹤0.01% |
452,400
+37,300
| +9% | +$457K |
|
1458
Axalta
AXTA
$7.95B
| $5.12M | ﹤0.01% |
172,945
+1,373
| +0.8% | +$39.3K |
|
|
AXON
1459
Axon Enterprise
AXON
$49B
| $5.07M | ﹤0.01% |
35,606
-3,116
| -8% | -$486K |
|
1460
Ciena
CIEN
$62.1B
| $5.04M | ﹤0.01% |
92,013
+8,399
| +10% | +$452K |
|
1461
Protara Therapeutics
TARA
$228M
| $5.03M | ﹤0.01% |
319,326
-114,272
| -26% | -$2.12M |
|
1462
Wyndham Hotels & Resorts
WH
$5.53B
| $4.97M | ﹤0.01% |
71,162
+5,062
| +8% | +$323K |
|
1463
Nordson
NDSN
$17.2B
| $4.94M | ﹤0.01% |
24,864
-276,003
| -92% | -$53.8M |
|
1464
Royal Bank of Canada
RY
$300B
| $4.91M | ﹤0.01% |
53,262
-5,440
| -9% | -$474K |
|
1465
Reinsurance Group of America
RGA
$16.2B
| $4.89M | ﹤0.01% |
38,808
+2,307
| +6% | +$274K |
|
1466
Omega Healthcare
OHI
$13.9B
| $4.86M | ﹤0.01% |
132,606
+1,348
| +1% | +$49.6K |
|
|
CMRC
1467
Commerce.com Inc Series 1
CMRC
$182M
| $4.86M | ﹤0.01% |
83,995
-298,206
| -78% | -$19.8M |
|
1468
Gentex
GNTX
$5B
| $4.83M | ﹤0.01% |
135,359
+5,396
| +4% | +$192K |
|
1469
Lithia Motors
LAD
$8.26B
| $4.82M | ﹤0.01% |
12,354
+213
| +2% | +$76.5K |
|
1470
ImmunityBio
IBRX
$7.92B
| $4.82M | ﹤0.01% |
+202,938
| New | +$5.26M |
|
1471
Oshkosh
OSK
$9.47B
| $4.8M | ﹤0.01% |
40,494
+2,102
| +5% | +$218K |
|
1472
Cleveland-Cliffs
CLF
$6.95B
| $4.76M | ﹤0.01% |
236,625
-11,853
| -5% | -$193K |
|
1473
Owens Corning
OC
$12.2B
| $4.75M | ﹤0.01% |
51,602
-4,007
| -7% | -$336K |
|
1474
GameStop
GME
$8.29B
| $4.74M | ﹤0.01% |
99,948
-18,128
| -15% | -$535K |
|
|
VIRX
1475
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $4.72M | ﹤0.01% |
+510,000
| New | +$5.31M |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.